Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group None., (2022), Lancet, 399, 143 - 151

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group None., (2021), The Lancet. Respiratory medicine, 9, 1419 - 1426

What is the association of COVID-19 with heart attacks and strokes?

Other

Mafham M. and Baigent C., (2021), Lancet, 398, 561 - 563

The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19.

Journal article

Pessoa-Amorim G. and Mafham MM., (2021), Cardiovasc Res, 117, e110 - e113

Making trials part of good clinical care: lessons from the RECOVERY trial.

Journal article

Pessoa-Amorim G. et al, (2021), Future Healthc J, 8, e243 - e250

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group None., (2021), Lancet, 397, 1637 - 1645

Dexamethasone in Hospitalized Patients with Covid-19.

Journal article

RECOVERY Collaborative Group None. et al, (2021), N Engl J Med, 384, 693 - 704

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612

Load More